Treatment of severe aplastic anemia with an immunosuppressive agent plus recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin

American Journal of Hematology

Volumn 59, Issue 3, 1998, Pages 185-191

  Shao, Zonghong ^a   Chu, Yulin ^a   Zhang, Yizhi ^a   Chen, Guibin ^a   Zheng, Yizhou ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Aplastic anemia; Epoietin alpha; Granulocyte macrophage colony stimulating factor; Hematopoietic growth factors; Immunosuppressive agents

Indexed keywords

CYCLOSPORIN; ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; IMMUNOSUPPRESSIVE AGENT; LYMPHOBLAST ANTIBODY; TESTOSTERONE ETHER;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BLOOD TRANSFUSION; CHILD; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; ERYTHROPOIESIS; FEMALE; HUMAN; INFECTION RATE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; RISK BENEFIT ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; BLOOD CELL COUNT; BLOOD TRANSFUSION; BONE MARROW CELLS; CELL COUNT; CHILD; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFECTION; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; REMISSION INDUCTION; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031732898     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199811)59:3<185::AID-AJH2>3.0.CO;2-3     Document Type: Article

References (30)

1. Chu YL, Hao YS, Bian SG, Shougen B, Yang CL, Yang TY, Yan WW, Liang H, Li JB, Chen Z, Gong X: Clinical study of the treatment of 23 cases of aplastic anemia with antilymphocyte globulin. Chin J Hematol 7:198, 1986.
2. Zhang Z: Diagnosis and Response Criteria of Blood Diseases. Tianjin, China: Tianjin Scientific and Technological Press, 1:35, 1991.
3. Young NS, Barrett AJ: The treatment of severe acquired aplastic anemia. Blood 85:3367, 1995.
4. Doney K, Leisenring W, Storb R, Appelbaum FR: Primary treatment of acquired aplastic anemia: Outcomes with bone marrow transplantation and immunosuppressive therapy. Ann Intern Med 126:107, 1997.
5. Camilla BM, Doney K: Immunosuppressive therapy for aplastic anemia: Indications, agents, mechanisms, and results. J Pediatr Hematol Oncol 12:411, 1990.
6. Paquette RL, Tebyani N, Frane M, Ireland P, Ho WG, Champlin RE, Nimer SD: Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin. Comparison with bone marrow transplantation. Blood 85:283, 1995.
7. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavacher A, Vogt HG, Hermann F, Freund M, Meusers P, Salama A, Heimpel H: Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 324:1297, 1991.
8. Rosenfeld SJ, Kimball J, Vining D, Young NS: Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 85:3058, 1995.
9. David HS: Use of hematopoietic growth factor for treatment of aplastic anemia. Am J Pediatr Hematol Oncol 12:425, 1990.
10. Vadan-Raj S, Buescher S, Broxmeyer HE, Lemaistre A, Lepe-zuniga JL, Ventura G, Jeha S, Horwitz, LJ, Trujillo JM, Gillis S, Hittelman WN, Gutterman JU.: Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. N Engl J Med 319:1628, 1988.
11. Nissen C, Tichelli A, Gratwohl A, Speck B, Milne A, Gordon Smith EC, Schaedelin J: Failure of recombinant human granulocyte-macrophage colony-stimulating factor therapy in aplastic anemia patients with very severe neutropenia. Blood 72:2045, 1988.
12. Antin JH, Smith BR, Holmes W, Rosenthal DS: Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood 72:705, 1988.
13. Champlin RE, Nimer SD, Ireland P, Oette DH, Golde DW: Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage colony-stimulating factor. Blood 73:694, 1989.
14. Bacigalupo A, Broccia G, Corda G, Arcese W, Carotennto M, Gallamini A, Locatelli F, Mori PG, Savacco P, Todeschini G, Coser P, Iacopino P, van Lint MT, Gluckman E: Antilymphocyte globulin, cyclosporine, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): A pilot study of the EBMT SAA working party. Blood 85:1348, 1995.
15. Hord JD, Gay JC, Whitlock JA, Janco RL, Edwards JR, Greer JP, Lukens JN: Long-term granulocyte-macrophage colony-stimulating factor and immunosuppression in the treatment of acquired severe aplastic anemia. J Pediatr Hematol Oncol 17:140, 1995.
16. Stebler C, Tichelli A, Dazzi H, Gratwohl A, Nissen C, Speck B: High-dose recombinant human erythropoietin for treatment of anemia in myelodystrophic syndrome and paroxysmal nocturnal hemoglobinuria: A pilot study. Exp Hematol 18:1204, 1990.
17. Cazzalo M, Ponchio L, Beguin Y, Rosti V, Bergamashi G, Liberato N, Fregoni V, Nalli G, Barosi G, Ascari E: Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood 79:29, 1992.
18. Greenberg P, Negrin R, Ginzton N: G-CSF synergizes with erythropoietin (EPO) for enhancing colony formation (BFU-E) in myelodystrophic syndromes (MDS). Blood 87:4076, 1996.
19. Takahashi M, Aoki A, Mito M, Nikkuni K, Ohtsuka T, Saitoh H, Moriyama Y, Shibata A: Combination therapy with rhGM-CSF and rhEpo for two patients with refractory anemia and aplastic anemia. Hematol Pathol 7(3):153, 1993.
20. Imamura M, Kobayashi M, Kobayashi S, Yoshida K, Mikuni C, Ishikawa Y, Matsumoto S, Sakamaki S, Nütsu Y, Hinoda Y: Combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in aplastic anemia. Am J Hematol 48:29, 1995.
21. Weide R, Lyttelton M, Samson D, Görg C, Köppler H, Pflüger KH, Havemann K: Sustained trilineage response in a patient with ALG-resistant severe aplastic anaemia after treatment with G-CSF, erythropoietin and cyclosporin A: Association of recovery with marked evaluation of serum alkaline phosphatase. Br J Haematol 85:608, 1993.
22. Camitta BM, Storb R, Thomas ED: Aplastic anemia: Pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med 306:712, 1982.
23. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor. N Engl J Med 327: 28, 1992.
24. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor. N Engl J Med 327: 99, 1992.
25. Bruno E, Miller ME, Hoffman R: Interacting cytokines regulate in vitro human megakaryocytopoiesis. Blood 73:671, 1989.
26. Hovgaard D, Mortensen BT, Schifter S, Nissen NI: Clinical pharmacokinetic studies of a human haemopoietic growth factor. GM-CSF. Eur J Clin Invest 22:45, 1992.
27. Cebon J, Lieschke GJ, Bury RW, Morstyn G: The dissociation of efficacy from toxicity according to route of administration: A pharmacodynamic study. Br J Haematol 80:144, 1992.
28. Schuster MW, Liu ET, Solberg LA, Stadtmauer E, Bennett JM, Israel RJ: Granulocyte-macrophage colony-stimulating factor (GM-CSF) for aplastic anemia (AA): Preliminary results of a multi-center, randomized, controlled trial. Blood 76:47a, 1990.
29. Guinan EC, Sieff CA, Oette DH, Nathan DG: A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia. Blood 76:1077, 1990.
30. Imashuku S, Hibi S, Nakajima F, Mitsui T, Yokoyama S, Kojima S, Matsuyama T, Nakahata T, Ueda K, Tsukimoto I, Hanawa Y: A review of 125 cases to determine the risk of myelodysplasia and leukemia in pediatric neutropenic patients after treatment with recombinant human granulocyte colony-stimulating factor (Letter). Blood 84:2380, 1994.